DJIA 17,102.68 4.23 0.02%
NASDAQ 4,597.00 16.73 0.37%
S&P 500 2,003.09 -0.28 -0.01%
market minute promo

AVANIR PHARMACEUTICALS (NASDAQ: AVNR)

6.09 -0.13 (-2.09%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AVNR $6.10 -2.01%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.25
Previous Close $6.22
Daily Range $6.07 - $6.30
52-Week Range $2.62 - $6.30
Market Cap $1.0B
P/E Ratio -13.23
Dividend (Yield) $0.00 (0.0%)
Volume 852,153
Average Daily Volume 1,907,156
Current FY EPS -$0.27

Sector

Healthcare

Industry

Drugs

AVANIR PHARMACEUTICALS (AVNR) Description

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases. Website: http://www.avanir.com/

News & Commentary

3 Biotech Stocks with Catalysts Incoming: Spectrum, Orexigen, and Avanir

For companies involved in the development of drugs, a PDUFA decision will meaningfully impact their stocks. With this in mind, there are several PDUFA decisions in upcoming months to watch for.

Will Avanir (AVNR) Continue to Surge Higher? - Tale of the Tape

Avanir Pharmaceuticals Announces Initiation Of Phase II Study of AVP-786 For The Adjunctive Treatmen

Avanir Pharmaceuticals Announces Initiation Of Phase II Study of AVP-786 For The Adjunctive Treatment Of Major Depressive Disorder

An Update On A Couple Of Small Biotech Plays

Biodel Q3 Loss Narrower than Expected, Gives Pipeline Update - Analyst Blog

Avanir's Q3 Loss in Line, Revenues Up on High Nuedexta Demand - Analyst Blog

Avanir Pharmaceuticals' (AVNR) CEO Keith Katkin on Q3 2014 Results - Earnings Call Transcript

Avanir Pharmaceuticals (AVNR) Q3 2014 Results - Earnings Call Webcast

Insider Trading Alert - HERO, AVNR And CNMD Traded By Insiders

Avanir to Conduct Phase II Study on AVP-786 for Depression - Analyst Blog

Avanir Pharmaceuticals Announces FDA Acceptance Of IND For AVP-786, Used For Adjunctive Treatment Of

Avanir Pharmaceuticals Announces FDA Acceptance Of IND For AVP-786, Used For Adjunctive Treatment Of Major Depressive Disorder

See More AVNR News...

AVNR's Top Competitors

AVNR $6.09 (-2.09%)
Current stock: AVNR
JNJ $103.19 (-0.52%)
Current stock: JNJ
NVS $93.29 (3.84%)
Current stock: NVS
RHHBY $36.50 (-0.04%)
Current stock: RHHBY